Bile and blood testing for bile duct cancer gene changes
Part of Cancer, Digestive system clinical trials.
This study looks at whether a bile sample and a blood sample can show the same gene changes found in a tumor biopsy for people with bile duct or gallbladder cancer. It aims to see if these simpler tests could be used instead of a tumor tissue sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older
- You must have advanced bile duct or gallbladder cancer, or doctors strongly suspect it
- You have not yet started your first anti-cancer treatment, or you had a relapse at least 6 months after surgery or chemotherapy
- A sample of your tumor is being or will be tested for gene changes
- You must be able to provide blood and bile samples, and a bile sample must be obtainable during a drainage procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
This study is collecting information and blood samples from people with biliary tract cancer to understand how certain markers and quality-of-life measures relate to treatment outcomes. The findings may help improve future care and support.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
This trial uses a blood test called ctDNA to look at the genetic makeup of your cancer. It aims to learn more about bile duct cancer and may help guide your treatment choices.
This study is testing a new blood test that looks for signs of DNA changes linked to biliary tract cancer. It aims to see if the test can find these cancers early. If you have biliary tract cancer or a high suspicion of it, you may be able to help.
Hear when a new Biliary Tract Cancer (BTC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.